Literature DB >> 30423039

Bacterial Pathogens Differed Between Neutropenic and Non-neutropenic Patients in the Same Hematological Ward: An 8-Year Survey.

Jun Zhu1, Kun Zhou1, Ying Jiang1, Huixia Liu1, Haitao Bai1, Jieling Jiang1, Yanrong Gao1, Qi Cai1, Yin Tong1, Xianmin Song1, Chun Wang1, Liping Wan1.   

Abstract

Background: Bacterial infections are very common among patients with hematological diseases. Scant data are available regarding differences in the epidemiology and biological features of bacterial infections in neutropenic and non-neutropenic patients.
Methods: The aim of this survey was to compare the bacterial pathogens in neutropenic and non-neutropenic patients in the same ward during an 8-year period.
Results: A total of 1139 bacterial strains were isolated from 1071 patients with hematological diseases. The percentage of Gram-negative bacteria was significantly higher in neutropenic patients than in non-neutropenic patients (70.4% vs. 55.0%, respectively, P < .01). In neutropenic patients, the most commonly-isolated bacterium was Pseudomonas aeruginosa, followed by Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, and Stenotrophomonas maltophilia. In respiratory exudates, Gram-negative bacteria were also more frequently isolated from neutropenic patients than from non-neutropenic patients (79.1% vs. 56.1%, respectively, P < .01). The proportion of non-fermentative Gram-negative bacilli was significantly higher in neutropenic patients than in non-neutropenic patients (52.9% vs. 30.5%, respectively, P < .01). In blood culture samples from neutropenic patients, the most frequently identified pathogens, apart from coagulase negative staphylococcus, were Gram-negative bacilli (58.2%). In addition, the proportion of Escherichia coli in neutropenic patients was significantly higher than that in non-neutropenic patients (P < .01). Escherichia coli and Klebsiella pneumoniae strains from neutropenic patients also produced extended-spectrum β-lactamases at a higher rate of than those strains from non-neutropenic patients (Escherichia coli, 57.6% vs. 30.3%, respectively, P < .01; Klebsiella pneumonia, 31.9% vs. 13.0%, respectively, P < .01). Conclusions: This study showed that there are significant differences in the epidemiology and biological features of bacteria isolated from neutropenic and non-neutropenic patients.

Entities:  

Mesh:

Year:  2018        PMID: 30423039     DOI: 10.1093/cid/ciy643

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  6 in total

1.  Antimicrobial Stewardship in Hematological Patients at the intensive care unit: a global cross-sectional survey from the Nine-i Investigators Network.

Authors:  Jordi Rello; Cristina Sarda; Djamel Mokart; Kostoula Arvaniti; Murat Akova; Alexis Tabah; Elie Azoulay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-09       Impact factor: 3.267

2.  Gram-Negative Bacteria Bloodstream Infections in Patients with Hematological Malignancies - The Impact of Pathogen Type and Patterns of Antibiotic Resistance: A Retrospective Cohort Study.

Authors:  Yishu Tang; Cong Xu; Han Xiao; Liwen Wang; Qian Cheng; Xin Li
Journal:  Infect Drug Resist       Date:  2021-08-12       Impact factor: 4.003

3.  SKAP2 is required for defense against K. pneumoniae infection and neutrophil respiratory burst.

Authors:  Giang T Nguyen; Lamyaa Shaban; Matthias Mack; Kenneth D Swanson; Stephen C Bunnell; David B Sykes; Joan Mecsas
Journal:  Elife       Date:  2020-04-30       Impact factor: 8.140

4.  [Application of bronchoalveolar lavage fluid in patients with pulmonary complications after allogeneic hematopoietic stem cell transplantation].

Authors:  S Li; L P Wan; G G Xie; A H Bao; Y Sun; W Shu; J L Jiang; J Yang; X M Song; C Wang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-10-14

5.  The Effect of Host Immunity on Predicting the Mortality of Carbapenem-Resistant Organism Infection.

Authors:  Qun Lin; Yue Wang; Ying Luo; Guoxing Tang; Shusheng Li; Yicheng Zhang; Liyan Mao; Weiyong Liu; Feng Wang; Ziyong Sun
Journal:  Front Cell Infect Microbiol       Date:  2020-09-10       Impact factor: 5.293

6.  [Chinese guidelines for the clinical application of antibacterial drugs for agranulocytosis with fever (2020)].

Authors: 
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-12-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.